Organon shares fall after Q4 profit miss
** Shares of healthcare firm Organon OGN.N fall 8% to $7.07 premarket **Co posts Q4 adj. profit of 63 cents/shr, below estimates of 73 cents/shr - LSEG estimates ** OGN posts Q4 revenue of $1.5 billion, compared to estimates of $1.54 billion ** OGN stock was down ~52% in 2025 (Reporting by Gnaneshwar Rajan in Bengaluru) ((Gnaneshwar.Rajan@thomsonreuters.com;))
Recent news on Organon & Co.
See all newsIndia's Sun Pharma misses debt fundraise goal as investors demand higher yields, bankers say
Brief: Organon & Co Says It Does Not Expect To Record Milestone Expense In Q3 2026
India's Persistent Systems plans debut rupee debt sale to fund acquisition, bankers say
India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
Organon & Co reports results for the quarter ended June 30 - Earnings Summary